Therefore, it is important for individuals to speak with a doctor about hives that keep returning. Keep reading to learn more about the symptoms, causes, diagnosis, and treatment of hives that ...

Jason Hawkes, MD, MS, provided an in-depth look at the potential role of dupilumab (Dupixent; Sanofi and Regeneron ...

Who Is This Treatment For? Chronic spontaneous urticaria, aka CSU, happens when a person develops itchy hives that persist for over six weeks. Their condition may not consistently be controlled by ...

Dupixent, which was rejected by the FDA for chronic spontaneous urticaria in October 2023, is now approved as the first new ...

The CSU indication is the seventh disease driven in part by underlying type 2 inflammation in which Dupixent has received approval.

A safety analysis of mRNA vaccination in a phase 1, randomized, open-label clinical trial evaluated the safety and ...

CHRONIC spontaneous urticaria (CSU) is a distressing inflammatory skin condition characterised by the recurrent appearance of ...

Depending on the cause, treatment can range from avoiding certain foods to taking prescription medications. The medical term for hives is urticaria, which describes a condition involving raised ...